ELV
ELEVANCE HEALTH INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
ELEVANCE HEALTH INC (ELV) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$1.90B; the largest are Jeremy Grantham, Seth Klarman, Ken Griffin. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 3 trimmed, 3 closed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders74 also report options
Congress trades20
Price$394.59vs quarter-end+2.03%
Sectors1
This quarter's moves
Top holderJeremy GranthamNew0
Added2
Trimmed / sold6
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Seth KlarmanHold
Value $493.14M9.1% of portfolio1,275,1542026 Q2
Dodge & CoxHold
Value $502.7K0.0% of portfolio1,3002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Seth Klarman | $493.14M | 9.1% | Hold |
| Dodge & Cox | $502.7K | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $77.15M— of portfolio199,5002026 Q2
Value $69.07M— of portfolio178,6002026 Q2
Value $32.60M— of portfolio84,3002026 Q2
Value $23.71M— of portfolio61,3002026 Q2
Value $9.67M— of portfolio25,0002026 Q2
Value $4.37M— of portfolio11,3002026 Q2
Value $2.32M— of portfolio6,0002026 Q2
Value $1.24M— of portfolio3,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $77.15M | — | — |
| Ken GriffinCALL | $69.07M | — | — |
| Izzy EnglanderPUT | $32.60M | — | — |
| Steven CohenCALL | $23.71M | — | — |
| Izzy EnglanderCALL | $9.67M | — | — |
| Paul Tudor JonesPUT | $4.37M | — | — |
| Steven CohenPUT | $2.32M | — | — |
| Paul Tudor JonesCALL | $1.24M | — | — |
Insider Trading
Officers · directors · Form 4Open-market purchases and sales (P/S)5
Ramiro G Peru
Director
Buy$366.1K1,000 @ $366.05Traded 2026-07-17Filed 2026-07-17Gail Boudreaux
President and CEO
Buy$249.2K680 @ $366.41Traded 2026-07-17Filed 2026-07-17Gail Boudreaux
President and CEO
Buy$753.1K2,045 @ $368.25Traded 2026-07-17Filed 2026-07-17Ronald W Penczek
CAO & Controller
Sell$148.8K369 @ $403.16Traded 2026-06-12Filed 2026-06-15Robert L Dixon JR
Director
Sell$60.7K151 @ $401.77Traded 2026-06-11Filed 2026-06-12
Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.